HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Trizivir (AZT+3HT+Abacavir) twice daily

TERMINATED · PHASE4 · HIV Infections

terminated

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.